Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

Houston Chronicle: Our Deadly, Costly Choices

March 29, 2011

In an editorial, the Houston Chronicle writes, "Last week, Texas state budget writers declined to include $19.2 million in additional funding for the Texas HIV Medication Program, which pays for essential medications for about 14,000 low-income Texans and is currently funded at $109 million. ... the program will have to be drastically restructured to accommodate the expected 14 percent growth in participants over the next two years ... the case for allocating priority funding for patients with HIV and AIDS is particularly strong when one considers both the human and economic costs of failing to do so" (3/28).

Back to other news for March 2011


This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Texas: Senate Plan Would Not Pay for New HIV Patients
More News and Articles on HIV Groups and Medical Care in Texas

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement